Funder: National Institutes of Health
Due Dates: June 18, 2025 | October 17, 2025 | February 18, 2026 | June 18, 2026 | October 19, 2026 | February 18, 2027 | June 18, 2027 | October 18, 2027
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years. Direct costs ≥$500,000/year require prior approval.
Summary: Supports investigator-initiated clinical trials in communication disorders (hearing, balance, smell, taste, voice, speech, language) that require FDA oversight, aim to establish efficacy, or pose higher participant risk.
Key Information: Only one clinical trial per application; multi-site trials require a trial management plan; prior consultation with NIDCD staff is strongly encouraged.